the rise of mrd in multiple myeloma: could this be an answer to a cure?
Published 6 years ago • 98 plays • Length 1:33Download video MP4
Download video MP3
Similar videos
-
2:13
the impact of mrd in apheresis product in patients with myeloma undergoing autosct
-
2:06
an insight into the sequencing of car-t and bispecifics in myeloma
-
11:23
challenges and future perspectives for minimal residual disease (mrd) in multiple myeloma
-
3:10
the importance of mrd in multiple myeloma in guiding treatment decisions & access to therapies
-
1:26
mrd in myeloma: the fda perspective
-
0:59
defining the origins of multiple myeloma
-
1:05
are we ready for mrd-guided therapy in multiple myeloma?
-
6:23
how long will i live with multiple myeloma, and is there a cure? #myeloma
-
13:58
genesis gv60 premium - latest expert review 2022 by dc ev
-
49:36
experience with mm mrd in our clinical laboratory: theory and practice
-
8:42
assessing mrd in multiple myeloma
-
2:24
the importance of mrd in multiple myeloma patients
-
1:20
mrd in myeloma
-
1:07
mrd-guided treatment in multiple myeloma
-
3:15
the evolution of mrd for myeloma
-
3:40
what’s new in minimal residual disease (mrd) detection in myeloma?
-
2:17
mrd: a promising biomarker in multiple myeloma
-
2:17
extended follow-up of the master trial
-
3:23
a bright future for multiple myeloma
-
2:01
real-world results of an in-class transition from vrd to ird in myeloma
-
19:41
multiple myeloma: minimal residual disease
-
0:45
how risk assessment in myeloma is changing with the emergence of mrd